Talking About Tumors with Ryann and Ryan - A medical oncology podcast
Talking About Tumors
50 episodes
6 months ago
1. Nomenclature, unique considerations 2. Secretory Syndromes 3. Somatostatin directed therapy 4. Peptide Receptor Radionucleotide Therapy Citations As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice. DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and ...
All content for Talking About Tumors with Ryann and Ryan - A medical oncology podcast is the property of Talking About Tumors and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
1. Nomenclature, unique considerations 2. Secretory Syndromes 3. Somatostatin directed therapy 4. Peptide Receptor Radionucleotide Therapy Citations As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice. DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and ...
03_11 Mesothelioma and a bit of Large Cell Neuroendocrine Carcinoma
Talking About Tumors with Ryann and Ryan - A medical oncology podcast
29 minutes
2 years ago
03_11 Mesothelioma and a bit of Large Cell Neuroendocrine Carcinoma
1. Presentation, and considerations for regional mesothelioma2. Systemic therapy options for advanced mesothelioma3. Corticosteroids for pemetrexed, paclitaxel and docetaxel4. A quick review on considerations for LCNEC CitationsAs always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice.DeVita, Vincent ...
Talking About Tumors with Ryann and Ryan - A medical oncology podcast
1. Nomenclature, unique considerations 2. Secretory Syndromes 3. Somatostatin directed therapy 4. Peptide Receptor Radionucleotide Therapy Citations As always, citations, and sources include education from our respective training programs, the Devita textbook, and Uptodate.com. We highly encourage review of guidelines published by ASCO, ESMO and other organizations local to your practice. DeVita, Vincent T., Jr., Theodore S. Lawrence, and Steven A. Rosenberg. Devita, Hellman, and ...
